Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
"I personally feel that we should aggressively work on opening schools because it has really af-fected the young generation in terms of knowledge and especially the marginalised ones who can't go for online classes, they are suffering"
DrRandeepGuleria
Director
All India Institute of Medical Sciences (AIIMS)
Sponsor
Patient Safety Capsules
Sharp rise in spurious drugs as pandemic triggers huge demand for medicines: Nakul Pasricha
Bengaluru, June 21, 2021: Global enforcement agencies including Interpol have noticed an increase of substandard, spurious, falsely labelled, falsified, and counterfeit (SSFFC) incidents in pharmaceuticals and medical devices. The Covid-19 pandemic has triggered such frauds due to the unprecedented demand for medicines.
Drug makers hit by PSUs’ increase in prices of chemicals used in manufacturing APIs
Mumbai, June 22, 2021: Drug makers have been hit hard by public sector undertakings’ increase in prices of chemicals needed for manufacture of active pharmaceutical ingredients (APIs) for the past few months.
Drug Laws & Policy Injections
Health Ministry issues guidelines on operationalization of COVID care services for children & adolescentsMumbai, June 19, 2021: The Union Health Ministry has issued guidelines on operationalization of COVID care services for children and adolescents. "It is anticipated that there may be intermittent surges in the number of cases.
Working to develop Haryana into hub of pharma industry: Khattar Haryana, 25 June 2021: Haryana Chief Minister Manohar Lal Khattar on Friday said his government is working towards developing the state into a hub of pharmaceutical industry. "To materialise this, special incentives will be given for setting up pharma industries in Haryana," he said presiding over a meeting with the Confederation of In-dian Industry (CII).
DoP invites applications to manufacture CDA and artesunate under PLI schemeMumbai, June 19, 2021: The Department of Pharmaceuticals (DoP) has invited applications from eligible applicants to manufac-ture chemical synthesis based KSMs/drug intermediates (DIs) like cyclohexane diacetic acid (CDA) and other chemical synthesis based KSMs/drug Intermediates/ APIs like artesunate under the production linked incentive (PLI) scheme to boost domestic manufacturing.
Drug regulator NPPA asks pharma firms to cut prices in wake of GST rate reductionNew Delhi, June 17, 2021: The National Pharmaceutical Pricing Authority (NPPA) noted that a change in tax rates has an impact on the fixation of maximum retail prices (MRP) of various drugs and formulations.
Poor countries deprived of COVAX supply, says WHO chiefET Bureau, June 26, 2021: The head of the World Health Organization (WHO) has expressed concern over the unavailability of Co-vid-19 vaccines through the COVAX programme, people in the know told ET.
Health ministry asks AMCs to report ADRs on priority from drugs used in treatment of Covid-19Mumbai, June 23, 2021: The Union health ministry has asked adverse drug reaction (ADR) monitoring centres (AMCs) to report ADRs on priority from drugs used as prophylactic and in the treatment of Covid-19 through the new Sus-pected ADR Reporting Form.
Pharma Injections
Serum Institute begins manufacturing first batch of Covovax vaccineNew Delhi, Jun 25 2021: Serum Institute of India (SII) CEO Adar Poonawalla on Friday said that SII has this week begun manufac-turing the first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc.
Piramal Pharma completes acquisition of Hemmo PharmaceuticalsMumbai, June 23, 2021: Mumbai: In March, Piramal Enterprises, the parent company of Piramal Pharma, had announced the pro-posed acquisition. "We wish to inform you that PPL has completed the acquisition of Hemmo on 22nd June, 2021 and the transaction is now closed," Piramal Enterprises said in a regulatory filing on Wednesday..
Covaxin shows 77.8% efficacy in phase 3 trials; SEC nod to phase 3 data Mumbai, 23June 2021: The Drugs Controller General of India's Subject Expert Committee (SEC) has approved Bharat Biotech' Phase 3 trial efficacy data after questions were raised over the delay in announcing results.
Glenmark gets nod to manufacture & market anti-diabetic FDC of remogliflozine-tabonate& teneligliptin Mumbai, June 23, 2021: The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Glenmark Pharmaceuticals to manufacture and market the proposed fixed dose combination (FDC) of remogliflozinetabonate and teneligliptin.
Indian pharma evinces interest on supply chain trade finance to enable easier global trade: Swati Babel Bengaluru, June 18: India’s pharmaceutical supply chain is complex. There are always concerns about safety and product quality of the product in global trade. Sometimes there is lack of integration across the network having to deal with large number of players at every stage.
Mankind Pharma gets CDSCO panel nod for phase I trial of anti-diabetic drug, MKP10241 Mumbai, June 19, 2021: The subject expert committee of the Central Drugs Standard Control Organisation (CDSCO) has given its clearance to Mankind Pharma for conducting phase I clinical trial of MKP10241, a patented first in class novel anti-diabetic molecule.
Drug Dopes
Govt should review spending of pharma cos &govt research institutes on R&D: M RajendranChennai, June 28, 2021: It is high time for the Government of India to advise the pharmaceutical companies in the country to spend a certain percentage of their revenue on innovation of new drugs. Likewise, the government should review how the public sector research institutes are spending the government funds sanctioned for research and developments, observes M Rajendran, former drugs controller in Tamil Nadu who provides legal assistance to pharma companies. 
Glutathione known for its effective immunity generating properties in treating Co-vid-19: Dr Anish DesaiMumbai, June 26, 2021: Glutathione (GSH), known also as the master anti-oxidant, has been known for its effective immunity ge-nerating properties in treating Covid-19, stated Dr Anish Desai, director, strategic medical affairs, Adroit Biomed Ltd.
Hospitals body on verge of deal with J&J for one-dose vaccine supply from July Mumbai, June 26, 2021: The Association of Healthcare Providers (India), a body that represents small and medium hospitals, is close to striking a deal for procuring vaccines from Johnson & Johnson (J&J). AHPI expects the jabs to be delivered early next month and this could be the first vaccine developed by a US company that will be available in India.
Digital health solutions to play major role for heart failure patients through regular monitoring: DrKolwankar Mumbai, June 26 2021: Digital health solutions can play a major role in improving quality of life for heart failure patients through regular monitoring and symptom tracking, stated Dr. Sid Kolwankar, AVP clinical at Wellthy Therapeutics.
Production capacity of Amphotericin B goes up by five-fold New Delhi, 18June 2021: Ministry has allocated over 7.28 lakh vials of the drug. The country will have sufficient quantities of Amphotericin B drug, required for treating fungal disease mucormycosis, with the production capacity in India going up by five-fold to 3.75 lakh vials this month, said Mansukh Mandaviya said on Friday.
Serum Institute of India produces over 10 crore doses of Covishield in JuneNEW DELHI, PTI, 27June 2021: "We are committed to enhancing the production capacity of our Covishield vaccine and have been work-ing round-the-clock in spite of various challenges being faced by us because of COVID-19 pandemic.
National Injections
India has capacity to store Covid vaccines requiring low temperatures: Centre to Supreme Court New Delhi, June 27, 2021: The affidavit said that based on the requirement of both the universal immunisationprogramme and CO-VID-19 vaccination, the government has centrally procured and supplied cold chain equipment (CCE) to the states and Union territories (UTs).
Gujarat FDCA takes action against 115 offenders for black marketing of Covid-19 drugsMumbai, June 26, 2021: The Gujarat Food and Drug Control Administration (FDCA) has made a massive crackdown on 115 offenders for black marketing of key Covid-19 drugs like amphoterecin B and remdesivir injections in parts of Surat and Vadodara. It detected 35 such cases of black marketing of remdesivir and amphoterecin B in which hospital staff and medical representatives were involved.
Punjab govt to install 75 more oxygen plants by July end Chandigarh, June 27 2021: The Punjab government will install 75 more oxygen plants in the state by July end, boosting the supply of the life-saving gas ahead of a possible third Covid wave, Chief Secretary Vini Mahajan said on Sunday.
Karnataka sets up Genomic Surveillance Committee to generate surveillance data to control Covid-19 spread Bengaluru, June 17, 2021: Even as the Centre has mandated that genomic surveillance should be done on 5% of the Covid-19 posi-tive cases, the Karnataka government has set up a Covid-19 Genomic Surveillance Committee to guide its department of health and family welfare with a long-term public health perspective in collaboration with national and international stakeholders and related studies.
U'khand Ayurveda Doctors Can Prescribe Allopathic Medicine in 'Emergency', IMA Calls Decision 'Illegal' Dehradun, June 22, 2021: The Uttarakhand government on Monday gave a nod to Ayurveda doctors to prescribe allopathic medicines in an ‘emergency’ situation. The Indian Medical Council (IMA) an apex body of the allopathic practitioners, reacted sharply and termed the state government’s decision as ‘illegal’.
PM Modi reviews COVID-19 vaccination drive, says important to continue momentum New Delhi, June 26, 2021: It was noted that 128 districts in the country have vaccinated more than 50 per cent of over 45 years of population and 16 districts have vaccinated more than 90 per cent of this age group.
Global Injections
WHO releases global guidance for country validation of viral hepatitis B and C eliminationGeneva, June 28, 2021: New WHO Guidance for country validation of viral hepatitis B and C elimination is released during a joint EASL-CDC-ECDC and WHO symposium “Viral Hepatitis Elimination – Assessing the progress in 2021” at the EASL International Liver Congress 2021.
ADA 2021: AstraZeneca touts Bydureon trial win in children and adolescents with type 2 diabetes25 June 2021: As it approaches the end of a distinguished run, AstraZeneca’s type 2 diabetes franchise is showing its age. Sales are in decline for Byetta and Bydureon as they’ve been squeezed by formidable foes in Eli Lilly and BoehringerIngelheim’sTrulicity, Merck’s Januvia and Novo Nordisk’s duo of Victoza and Ozempic.
Singapore will continue to give mRNA vaccines for young men: Expert committee
28June 2021: Myocarditis and pericarditis are inflammatory conditions that affect the heart muscles and the outer lining of the heart respectively.
Scientists identify link between genetic changes and rare childhood cancer rhabdomyosarcoma
London, 25 June 2021: Genetic changes may help to improve decision making for the treatment of the rare and aggressive form of childhood cancer rhabdomyosarcoma, according to a new international study led by researchers at the Institute of Cancer Research, London (ICR).
Roche nabs FDA emergency nod for Actemra in severe COVID-19 despite mixed trial results
June 25, 2021: Roche’s Actemra may have turned up mixed results in COVID-19 clinical trials, but the FDA thinks the rheumatoid arthritis drug has shown enough benefit in some severe patients to deserve an emergency use authorization.
NHSX sets out new ‘patient-centred’ data strategy
United Kingdom, June 23, 2021: NHSX has set out a new draft strategy detailing how patients will gain control of and better access to their health and care data.
PSAIIF PILL
Experts caution about information gap in health and pharma industry as one of the prime concerns
Mumbai, June 25, 2021: Experts have cautioned about the information gap in the health and pharma industry as one of the prime concerns amidst the raging pandemic coupled with the shortage of resources.
Domestic IVD industry gains momentum due to favourablegovt policies and schemes: Experts
Mumbai, 28June 2021: Domestic IVD industry is gaining momentum due to favourable government policies and schemes such as production linked incentive (PLI) scheme and infrastructure push such as the development of medical device parks, according to experts.
Frequently Asked Questions
Does meditation increase the connectivity of neurons in our brain?
Meditation is a method of attaining awareness and interest, achieving a cognitively distinct and emotionally relaxed, and steady condition via a technique such as concentration or centering the mind on a specific object, idea, or behavior.
Most recent studies show that meditation is observed to increase the connectivity between neurons in the brain. It increases the network integration between the brain cells. Meditation increases neurogenesis by growing healthy neurons and providing them with the best neurochemicals. It also stimulates the brain in the most exact ways. Meditation is one of the biggest solutions when one wants to increase the effectiveness of neurons and the brain's functioning.
SUBSCRIBER'S SYMPTOM
Indian hospitals can slash costs with Intuitive’s Extended Use Programme with Da Vinci RAS instruments
Bengaluru, 26 Jun 2021: Indian healthcare providers can ensure affordable solutions to patients with Intuitive’s Extended Use Pro-gramme (EUP) for Da Vinci robotic assisted surgery (RAS) instruments. This is because EUP is designed to slash costs in patient care, said Mandeep Singh Kumar, VP&GM, Intuitive India.
Blog Addicts
Ms. Devanshi Saini, Medical Student, Says: I read a lot. Compared to the other newsletter I subscribe to, PSM-India Newsletter is top drawer- Ultimate!
Dr. NileshShakya, Senior Resident, Says:The fact that I've been a subscriber since 2015, attests to the fact that I enjoy the newsletter, especially the articles on recent development in Healthcare.
Dr. Aaiirah Khan, Gynecologist, Says:
I have subscribed to many newsletters, but PSM-India Newsletter is the best value of all.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
